“…The presence of oligoclonal bands may help in differentiating MS from brain tumours. The presence of IgH CDR3 in the CSF may be useful in differentiating CNS lymphoma from tumefactive MS [30]. Molecular markers of axonal damage/neuronal death, such as 14-3-3 protein, may be elevated in the CSF of MS patients, but they have not been specifically studied in tumour-like cases.…”